North America Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars)

PrintEmail
January 2024 - 153 Pages - From $2,600
(Excel Data Sheet: $1,500)
Description

The report cover may be different from the image shown.

  • The product will be delivered as a PDF file by Email within 48 business hours upon receiving an order. 
  • To learn more about the report, please Download Free Sample Pages and Download Excel Datasheet Sample. The report will be updated before delivery, so that the most recent historic year is the base year and forecast covers 5-10 years over the base year.
  • Please Contact Us for any question, custom research, and current discount. It is possible now to buy a part of the report such as chapters, sections, data tables or figures.
  • For details about the license types, please refer to our Terms of Service 
Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

 

North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical trials and approvals for novel biomedicines, escalating healthcare spending, and favorable reimbursement policies.
Highlighted with 36 tables and 83 figures, this 153-page report “North America Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America biopharmaceuticals market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify the North America biopharmaceuticals market in every aspect of the classification from perspectives of Product Type, Testing Service, Raw Material, Classification, Therapeutic Area, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Monoclonal Antibodies
o Anti-cancer Monoclonal Antibodies
o Anti-inflammatory Monoclonal Antibodies
o Other Monoclonal Antibodies
• Recombinant Growth Factors
o Erythropoietin
o Granulocyte Colony Stimulating Factor
• Purified Proteins
o Leukemia Inhibitory Factor (LIF)
o P53 Protein
o P38 Protein
o Other Purified Proteins
• Recombinant Proteins
o Serum Albumin
o Amyloid Protein
o Defensin
o Transferrin
• Recombinant Hormones
o Recombinant Human Growth Hormones
o Recombinant Insulin
o Other Recombinant Hormones
• Vaccines
o Recombinant Vaccines
 Cancer Vaccines
 Malaria Vaccines
 Ebola Vaccines
 Hepatitis Vaccines
 Tetanus Vaccines
 Diphtheria Vaccines
 Cholera Vaccines
 Other Recombinant Vaccines
o Conventional Vaccines
 Polio Vaccines
 Pox Vaccines
 Other Conventional Vaccines
• Recombinant Enzymes
o Enterokinase
o Cyclase
o Caspase
o Cathepsin
• Cell and Gene Therapies
o Allogenic Products
o Autologous Products
o Acellular Products
• Synthetic Immunomodulators
• Other Product Types
o Blood Factors
o Other Products

Based on Testing Service, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Laboratory Testing
• Custom Testing/Customer Proprietary Testing
• Compendial and Multi Compendial Laboratory Testing

By Raw Material, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Formulation Excipients
• Active Pharmaceutical Ingredients (API)
• Other Materials

By Classification, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Innovative Biopharmaceuticals
• Biogenerics and Biosimilars

By Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Oncology
• Inflammatory and Infectious Diseases
• Autoimmune Disorders
• Metabolic Disorders
• Hormonal Disorders
• Cardiovascular Diseases
• Neurological Diseases
• Other Therapeutic Areas

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2023-2033. The breakdown of national markets by Product Type and Therapeutic Area over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict 28
2.1.4 Impact of Israel-Palestine War 30
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 40
2.4 Emerging Opportunities and Market Trends 43
2.5 Porter’s Fiver Forces Analysis 47
3 Segmentation of North America Market by Product Type 51
3.1 Market Overview by Product Type 51
3.2 Monoclonal Antibodies 53
3.2.1 Anti-cancer Monoclonal Antibodies 54
3.2.2 Anti-inflammatory Monoclonal Antibodies 55
3.2.3 Other Monoclonal Antibodies 56
3.3 Recombinant Growth Factors 57
3.3.1 Erythropoietin 58
3.3.2 Granulocyte Colony Stimulating Factor 59
3.4 Purified Proteins 60
3.4.1 Leukemia Inhibitory Factor (LIF) 61
3.4.2 P53 Protein 62
3.4.3 P38 Protein 63
3.4.4 Other Purified Proteins 64
3.5 Recombinant Proteins 65
3.5.1 Serum Albumin 66
3.5.2 Amyloid Protein 67
3.5.3 Defensin 68
3.5.4 Transferrin 69
3.6 Recombinant Hormones 70
3.6.1 Recombinant Human Growth Hormones 71
3.6.2 Recombinant Insulin 73
3.6.3 Other Recombinant Hormones 74
3.7 Vaccines 75
3.7.1 Recombinant Vaccines 76
3.7.2 Conventional Vaccines 78
3.8 Recombinant Enzymes 79
3.8.1 Enterokinase 80
3.8.2 Cyclase 81
3.8.3 Caspase 82
3.8.4 Cathepsin 83
3.9 Cell and Gene Therapies 84
3.9.1 Allogenic Products 85
3.9.2 Autologous Products 86
3.9.3 Acellular Products 87
3.10 Synthetic Immunomodulators 88
3.11 Other Product Types 89
3.11.1 Blood Factors 90
3.11.2 Other Products 91
4 Segmentation of North America Market by Testing Service 92
4.1 Market Overview by Testing Service 92
4.2 Laboratory Testing 94
4.3 Custom Testing/Customer Proprietary Testing 95
4.4 Compendial and Multi Compendial Laboratory Testing 96
5 Segmentation of North America Market by Raw Material 97
5.1 Market Overview by Raw Material 97
5.2 Formulation Excipients 99
5.3 Active Pharmaceutical Ingredients (API) 100
5.4 Other Materials 101
6 Segmentation of North America Market by Classification 102
6.1 Market Overview by Classification 102
6.2 Innovative Biopharmaceuticals 104
6.3 Biogenerics and Biosimilars 105
7 Segmentation of North America Market by Therapeutic Area 106
7.1 Market Overview by Therapeutic Area 106
7.2 Oncology 108
7.3 Inflammatory and Infectious Diseases 109
7.4 Autoimmune Disorders 110
7.5 Metabolic Disorders 111
7.6 Hormonal Disorders 112
7.7 Cardiovascular Diseases 113
7.8 Neurological Diseases 114
7.9 Other Therapeutic Areas 115
8 North America Market 2023-2033 by Country 116
8.1 Overview of North America Market 116
8.2 U.S. 119
8.3 Canada 122
8.4 Mexico 124
9 Competitive Landscape 126
9.1 Overview of Key Vendors 126
9.2 New Product Launch, Partnership, Investment, and M&A 130
9.3 Company Profiles 131
Abbott Laboratories 131
Amgen Inc. 133
Astrazeneca PLC 134
Bayer AG 135
Biogen Inc. 136
Bristol-myers Squibb Company (BMS) 137
Eli Lilly and Company 138
F. Hoffmann-La Roche Ltd. 139
Glaxosmithkline PLC 140
Johnson & Johnson 141
Merck & Co. Inc. 142
Novartis Ag 143
Novo Nordisk As 144
Pfizer Inc. 145
Sanofi Sa 146
Sharp Packaging Services 147
Sun Pharmaceutical Industries Ltd. 148
Takeda Pharmaceutical Company Limited 149
Thermo Fisher Scientific Inc. 150
Vertex Pharmaceuticals 151
WuXi AppTec 152
RELATED REPORTS 153

List of Tables:

Table 1. Snapshot of North America Biopharmaceuticals Market in Balanced Perspective, 2023-2033 19
Table 2. World Economic Outlook, 2024-2036 23
Table 3. World Economic Outlook, 2022-2024 25
Table 4. Scenarios for Economic Impact of Ukraine Crisis 29
Table 5. Scenarios for Economic Impact of Israel-Palestine War 30
Table 6. World Health Spending by Region, $ bn, 2013-2020 35
Table 7. Total Number of Registered Clinical Studies Worldwide, 2010-2021 36
Table 8. Worldwide Number of New Cancer by Type, 2020 37
Table 9. Main Product Trends and Market Opportunities in North America Biopharmaceuticals Market 43
Table 10. North America Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 51
Table 11. North America Biopharmaceuticals Market: Monoclonal Antibodies by Type, 2023-2033, $ mn 53
Table 12. North America Biopharmaceuticals Market: Recombinant Growth Factor by Type, 2023-2033, $ mn 57
Table 13. North America Biopharmaceuticals Market: Purified Proteins by Type, 2023-2033, $ mn 60
Table 14. North America Biopharmaceuticals Market: Recombinant Proteins by Type, 2023-2033, $ mn 65
Table 15. North America Biopharmaceuticals Market: Recombinant Hormones by Type, 2023-2033, $ mn 70
Table 16. Selected Drugs for COVID-19 Treatment in Development, Nov 2022 72
Table 17. North America Biopharmaceuticals Market: Vaccines by Type, 2023-2033, $ mn 75
Table 18. North America Biopharmaceuticals Market: Recombinant Vaccines by Type, 2023-2033, $ mn 77
Table 19. North America Biopharmaceuticals Market: Conventional Vaccines by Type, 2023-2033, $ mn 78
Table 20. North America Biopharmaceuticals Market: Recombinant Enzymes by Type, 2023-2033, $ mn 79
Table 21. North America Biopharmaceuticals Market: Cell and Gene Therapies by Type, 2023-2033, $ mn 84
Table 22. North America Biopharmaceuticals Market: Other Product Types by Type, 2023-2033, $ mn 89
Table 23. North America Biopharmaceuticals Market by Testing Service, 2023-2033, $ mn 92
Table 24. North America Biopharmaceuticals Market by Raw Material, 2023-2033, $ mn 97
Table 25. North America Biopharmaceuticals Market by Classification, 2023-2033, $ mn 102
Table 26. North America Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 106
Table 27. North America Biopharmaceuticals Market by Country, 2023-2033, $ mn 117
Table 28. U.S. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 121
Table 29. U.S. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 121
Table 30. Canada Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 123
Table 31. Canada Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 123
Table 32. Mexico Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 125
Table 33. Mexico Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 125
Table 34. Abbott Laboratories: Company Snapshot 131
Table 35. Abbott Laboratories: Business Segmentation 132
Table 36. Abbott Laboratories: Product Portfolio 132

 

 

List of Figures:

Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 18
Figure 4. North America Biopharmaceuticals Market, 2023-2033, $ mn 21
Figure 5. Impact of COVID-19 on Business 26
Figure 6. Primary Drivers and Impact Factors of North America Biopharmaceuticals Market 31
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 34
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 34
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022 35
Figure 10. Primary Restraints and Impact Factors of North America Biopharmaceuticals Market 40
Figure 11. Investment Opportunity Analysis 44
Figure 12. Porter’s Fiver Forces Analysis of North America Biopharmaceuticals Market 47
Figure 13. Breakdown of North America Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue 52
Figure 14. North America Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%) 52
Figure 15. North America Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn 53
Figure 16. North America Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn 54
Figure 17. North America Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn 55
Figure 18. North America Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn 56
Figure 19. North America Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn 57
Figure 20. North America Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn 58
Figure 21. North America Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn 59
Figure 22. North America Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn 60
Figure 23. North America Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn 61
Figure 24. North America Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn 62
Figure 25. North America Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn 63
Figure 26. North America Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn 64
Figure 27. North America Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn 65
Figure 28. North America Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn 66
Figure 29. North America Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn 67
Figure 30. North America Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn 68
Figure 31. North America Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn 69
Figure 32. North America Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn 70
Figure 33. North America Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn 71
Figure 34. North America Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn 73
Figure 35. North America Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn 74
Figure 36. North America Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn 75
Figure 37. North America Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn 76
Figure 38. North America Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn 78
Figure 39. North America Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn 79
Figure 40. North America Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn 80
Figure 41. North America Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn 81
Figure 42. North America Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn 82
Figure 43. North America Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn 83
Figure 44. North America Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn 84
Figure 45. North America Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn 85
Figure 46. North America Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn 86
Figure 47. North America Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn 87
Figure 48. North America Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn 88
Figure 49. North America Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn 89
Figure 50. North America Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn 90
Figure 51. North America Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn 91
Figure 52. Breakdown of North America Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue 93
Figure 53. North America Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%) 93
Figure 54. North America Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn 94
Figure 55. North America Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn 95
Figure 56. North America Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn 96
Figure 57. Breakdown of North America Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue 98
Figure 58. North America Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%) 98
Figure 59. North America Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn 99
Figure 60. North America Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn 100
Figure 61. North America Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn 101
Figure 62. Breakdown of North America Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue 103
Figure 63. North America Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%) 103
Figure 64. North America Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn 104
Figure 65. North America Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn 105
Figure 66. Breakdown of North America Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue 107
Figure 67. North America Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%) 107
Figure 68. North America Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn 108
Figure 69. North America Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn 109
Figure 70. North America Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn 110
Figure 71. North America Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn 111
Figure 72. North America Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn 112
Figure 73. North America Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn 113
Figure 74. North America Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn 114
Figure 75. North America Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn 115
Figure 76. Breakdown of North America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 117
Figure 77. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 118
Figure 78. U.S. Biopharmaceuticals Market, 2023-2033, $ mn 120
Figure 79. Venture Capital Deal Activity and Investment Flows in the U.S., 2013-2022, $ bn and Deal Counts 120
Figure 80. Canada Biopharmaceuticals Market, 2023-2033, $ mn 122
Figure 81. Biopharmaceuticals Market in Mexico, 2023-2033, $ mn 124
Figure 82. Growth Stage of North America Biopharmaceuticals Industry over the Forecast Period 126
Figure 83. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn 128

 

Reviews

There are yet no reviews for this product.